首页> 外文OA文献 >Self-cleavage of fusion protein in vivo using TEV protease to yield native protein
【2h】

Self-cleavage of fusion protein in vivo using TEV protease to yield native protein

机译:使用TEV蛋白酶在体内自我切割融合蛋白以产生天然蛋白

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Overproduction of proteins from cloned genes using fusion protein expression vectors in Escherichia coli and eukaryotic cells has increased the quantity of protein produced. This approach has been widely used in producing soluble recombinant proteins for structural and functional analysis. One major disadvantage, however, of applying this approach for clinical or bioindustrial uses is that proteolytic removal of the fusion carrier is tedious, expensive, and often results in products with additional amino acid residues than the native proteins. Here we describe a new method for productions of native proteins with original amino termini in vivo via intracellular self-cleavage of the fusion protein using tobacco etch virus (TEV) protease. Our design allows one to simultaneously clone any gene into multiple fusion protein vectors using two unique cloning sites (i.e., SnaBI and XhoI) without restriction digestion, and then rapidly identifies those constructs producing soluble native proteins. This method will make the fusion protein approach more feasible for protein drug research.
机译:在大肠杆菌和真核细胞中使用融合蛋白表达载体从克隆基因中过量生产蛋白质,增加了所产生蛋白质的数量。该方法已被广泛用于生产可溶性重组蛋白以进行结构和功能分析。然而,将该方法用于临床或生物工业用途的一个主要缺点是融合载体的蛋白水解去除是繁琐,昂贵的,并且通常导致产物具有比天然蛋白质更多的氨基酸残基。在这里,我们描述了一种新的生产天然蛋白的新方法,该蛋白通过使用烟草蚀刻病毒(TEV)蛋白酶通过融合蛋白的细胞内自我切割在体内产生原始氨基末端。我们的设计允许使用两个独特的克隆位点(即SnaBI和XhoI)将任何基因同时克隆到多个融合蛋白载体中,而无需进行限制性酶切消化,然后快速鉴定出那些产生可溶性天然蛋白的构建体。这种方法将使融合蛋白方法对于蛋白质药物的研究更加可行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号